Fig. 4
Forest plot showing the effect of glucagon-like peptide-1 (GLP-1) receptor agonists on urinary albumin excretion in terms of the weighted mean difference and 95% fiducial intervals
Fig. 4 | BMC Endocrine Disorders
Forest plot showing the effect of glucagon-like peptide-1 (GLP-1) receptor agonists on urinary albumin excretion in terms of the weighted mean difference and 95% fiducial intervals